Table 2

Animals challenged (0.1 or 1.0 ID50) and infected after pre-treatment with test agent or PBS

Agent administered 12 h before viral challenge

Challenge dose 0.1 ID50

Challenge dose 1.0 ID50

Fold-increase susceptibility


GML in K-Y Warming Jelly

21/40 (53%)

*

10


K-Y Warming Jelly

18/39 (46%)

*

7


PBS

*

21/40 (53%)

Reference


*The exposures at challenge doses in these cells were not performed concurrently with the experiment reported in this Table, but results from previously performed experiments at these doses are shown in Table 1 and Fig. 1.

Moench et al. BMC Infectious Diseases 2010 10:331   doi:10.1186/1471-2334-10-331

Open Data